References
- WHO Collaborating Centre for International Drug Monitoring. Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. London, EQUUS, 2000.
- Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005; 5(4): 309-16. https://doi.org/10.1097/01.all.0000173785.81024.33
- Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK and Breckenridge AM. Adverse drug reaction as cause of admission to hospital: prospective analysis of 18820 patient. BMJ 2004; 329: 15-19. https://doi.org/10.1136/bmj.329.7456.15
- Kongkaew C, Noyce PR, Ashcroft DM. H. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008; 42(7): 1017-25. https://doi.org/10.1345/aph.1L037
- 최정희, 신유섭, 서창희, 남동호, 박해심. 단일 3차 의료기관에서 약물 이상반응의 빈도. 대한내과학회지 2004; 67(3): 290-296.
- Schnyder B, Pichler WJ. Mechanism of Drug-Induced Allergy. Mayo Clin Proc 2009; 84(3): 268-72. https://doi.org/10.4065/84.3.268
- Tan V A K, Gerez I F A, Van Bever HP. Prevalence of drug allergy in Singaporean children. Singapore Med J 2009; 50(12): 1158-61.
- Gruchalla R. Understanding drug allergies. J Allergy Clin Immunol 2000; 105: S637-44. https://doi.org/10.1067/mai.2000.106156
- Thomsen LA, Winterstein AG, Sondergaard B, Haugbolle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007; 41(9): 1411-26. https://doi.org/10.1345/aph.1H658
- Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Sweitzer BJ, Shea BF, Hallisey R, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274(1): 29-34. https://doi.org/10.1001/jama.274.1.29
- Winterstein AG, Sauer BC, Hepler CD, and Poole Charles. Preventable drug-related hospital admission. Ann Pharmacother 2002; 36: 1238-48. https://doi.org/10.1345/aph.1A225
- Howard RL, Avery AJ, Howard PD and Patridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual. Saf. Health Care 2003; 12: 280-85. https://doi.org/10.1136/qhc.12.4.280
- Beijer HJ, de Blaey CJ. Hospitalizations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24(2): 46-54. https://doi.org/10.1023/A:1015570104121
- 김세현, 홍종수, 최지호, 이상현. 처방된 약물의 부작용에 대 해환자가알기원하는범위. 가정의학회지. 2002; 23(1): 104-110.
- 지은희. 소비자의 의약품 안전 정보에 대한 인식정도와 정보 획득경로에 관한 연구. 숙명여자대학교 임상대학원 석사학위논문. 2004.
- Longtin Y, Sax H, Leape LL, Sheridan SE, Donaldson L, Pittet D. Patient participation: current knowledge and applicability to patient safety. Mayo Clin Proc 2010; 85(1): 53-62. https://doi.org/10.4065/mcp.2009.0248
- 김윤정. 의약 분업 후 개국 약사의 역할에 대한 환자의 이해도 및 만족도 평가. 숙명여자대학교 임상약학대학원 석사학위논문. 2001
- Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, Bates DW. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282(3): 267-70. https://doi.org/10.1001/jama.282.3.267